These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16799407)

  • 41. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of diabetes mellitus using an external insulin pump: the state of the art.
    Hanaire H; Lassmann-Vague V; Jeandidier N; Renard E; Tubiana-Rufi N; Vambergue A; Raccah D; Pinget M; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):401-23. PubMed ID: 18951116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy.
    Guinn TS; Bailey GJ; Mecklenburg RS
    Diabetes Care; 1988 Jan; 11(1):46-51. PubMed ID: 3123187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients.
    Mecklenburg RS; Guinn TS; Sannar CA; Blumenstein BA
    Diabetes Care; 1986; 9(4):351-5. PubMed ID: 3743310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous subcutaneous insulin infusion: Special needs for children.
    Adolfsson P; Ziegler R; Hanas R
    Pediatr Diabetes; 2017 Jun; 18(4):255-261. PubMed ID: 28425167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with discontinuation of continuous subcutaneous insulin infusion.
    Bell DS; Ackerson C; Cutter G; Clements RS
    Am J Med Sci; 1988 Jan; 295(1):23-8. PubMed ID: 3122566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years.
    Cope JU; Samuels-Reid JH; Morrison AE
    J Diabetes Sci Technol; 2012 Sep; 6(5):1053-9. PubMed ID: 23063031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a Real-time Force-based Algorithm for Infusion Failure Detection.
    Blanco LE; Wilcox JH; Hughes MS; Lal RA
    J Diabetes Sci Technol; 2024 Apr; ():19322968241247530. PubMed ID: 38654491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation at Site of Insulin Infusion Diminishes Glycemic Control.
    Kesserwan S; Lewis BE; Mao L; Sharafieh R; Atwood T; Kreutzer DL; Klueh U
    J Pharm Sci; 2022 Jul; 111(7):1952-1961. PubMed ID: 34986358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations.
    Butterfield RD; Sims NM
    IEEE Open J Eng Med Biol; 2024; 5():593-599. PubMed ID: 39157058
    [No Abstract]   [Full Text] [Related]  

  • 56. What could be the reasons for giving up the implanted pump treatment?
    Schaepelynck-Bélicar P; Dufaitre-Patouraux L; Lassmann-Vague V
    Diabetes Metab; 2005 Feb; 31(1):87-9. PubMed ID: 15803119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A hazard analysis for a generic insulin infusion pump.
    Zhang Y; Jones PL; Jetley R
    J Diabetes Sci Technol; 2010 Mar; 4(2):263-83. PubMed ID: 20307387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters.
    Hauzenberger JR; Münzker J; Kotzbeck P; Asslaber M; Bubalo V; Joseph JI; Pieber TR
    Sci Rep; 2018 Jan; 8(1):1132. PubMed ID: 29348570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interference at work: a case report of a malfunctioning insulin pump.
    Reiher AE; Gallagher TA; Emanuele MA
    Endocrine; 2009 Feb; 35(1):22-4. PubMed ID: 19082930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. We Need More Research and Better Designs for Insulin Infusion Sets.
    Heinemann L; Walsh J; Roberts R
    J Diabetes Sci Technol; 2014 Mar; 8(2):199-202. PubMed ID: 24876567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.